Ultrasound Measurements of Hepatic Vasculatures and Hepatic Doppler Assessment of Healthy Children
1 other identifier
observational
300
1 country
1
Brief Summary
Flow dynamics in the liver is altered in different hepatobiliary and cardiac pathologies, causing changes in hepatic vasculatures sizes and flow pattern changes which can be assessed by ultrasound (USG) study. Before one can use these measurements and observations to diagnose pathologies, a clear grasp of normality is crucial. In the field of pediatrics, this is particularly challenging as the normal range of measurements may change with age, weight, height, gender and race of children. Taking hepatic veno-occlusive disease as an example, current literature is conflicting regarding whether sonographic findings show consistent association with the disease. Sonographic findings therefore now have limited role in contributing to the diagnosis. This may be related to the lack of a robust age corrected normal range of measurement for reference. Existing literature shows that the normal portal vein diameter varies with age, weight and height and possibly gender. Literature for normal measurements of hepatic vein and hepatic artery in children is lacking. In this study, the investigators aim to conduct a prospective, cross-section observational study to establish the normal measurements ranges of hepatic vein, hepatic artery and portal vein in healthy children in the investigators' locality. Flow patterns, including qualitative assessment and quantitative measurements of resistive index and flow velocities will also be assessed. These age corrected normal measurements will be very helpful in the diagnosis and follow-up of hepatobiliary and cardiac pathologies associated with alterations in dynamics of hepatic circulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedFirst Posted
Study publicly available on registry
November 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 29, 2024
February 1, 2024
3.7 years
October 29, 2020
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (24)
Hepatic veins diameter (in mm) measured by grey scale ultrasound at 1 - 2 cm from confluence with inferior vena cava
Right, middle and left hepatic vein diameter (in mm) measured by grey scale Ultrasound at location 1 - 2 cm from confluence with inferior vena cava, measured in longitudinal axis
Baseline
Hepatic veins Doppler assessment of flow direction (towards or away from inferior vena cava)
Ultrasound Doppler assessment of right, middle and left hepatic veins for flow direction (towards or away from inferior vena cava)
Baseline
Hepatic veins Doppler assessment of flow pulsatility (yes or no)
Ultrasound Doppler assessment of right, middle and left hepatic veins for flow pulsatility (yes or no)
Baseline
Hepatic veins Doppler assessment of flow phasicity (monophasic, biphasic or triphasic)
Ultrasound Doppler assessment of right, middle and left hepatic veins for flow phasicity (monophasic, biphasic or triphasic)
Baseline
Hepatic veins Quantitative Doppler measurement of maximum flow rate (cm/s)
Ultrasound Doppler quantitative measurement of right, middle and left hepatic veins maximum flow rate (cm/s)
Baseline
Hepatic veins Quantitative Doppler measurement of minimum flow rate (cm/s)
Ultrasound Doppler quantitative measurement of right, middle and left hepatic veins minimum flow rate (cm/s)
Baseline
Hepatic veins Quantitative Doppler measurement of pulsatility index (only if pulsatility is present)
Ultrasound Doppler quantitative measurement of right, middle and left hepatic veins pulsatility index (Only if pulsatility is present)
Baseline
Hepatic artery diameter (in mm) measured by grey scale ultrasound at liver hilum
Hepatic artery diameter (in mm) measured by grey scale ultrasound at the hepatic hilum (longitudinal axis)
Baseline
Hepatic artery Doppler assessment of flow direction (hepatofugal or hepatopetal)
Ultrasound Doppler assessment of hepatic artery flow direction (hepatofugal or hepatopetal)
Baseline
Hepatic artery Doppler assessment of flow pulsatility (yes or no)
Ultrasound Doppler assessment of hepatic artery flow pulsatility (yes or no)
Baseline
Hepatic artery Doppler assessment of flow phasicity (monophasic, biphasic or triphasic)
Ultrasound Doppler assessment of hepatic artery flow phasicity (monophasic, biphasic or triphasic)
Baseline
Hepatic artery quantitative Doppler measurement of peak systolic velocity (cm/s)
Ultrasound Doppler quantitative measurement of hepatic artery peak systolic velocity (cm/s)
Baseline
Hepatic artery quantitative Doppler measurement of end diastolic velocity (cm/s)
Ultrasound Doppler quantitative measurement of hepatic artery end diastolic velocity (cm/s)
Baseline
Hepatic artery quantitative Doppler measurement of pulsatility index
Ultrasound Doppler quantitative measurement of hepatic artery pulsatility index
Baseline
Hepatic artery quantitative Doppler measurement of resistive index
Ultrasound Doppler quantitative measurement of hepatic artery resistive index
Baseline
Hepatic artery quantitative Doppler measurement of flow volume (ml/s) (measured if feasible)
Ultrasound Doppler quantitative measurement of hepatic artery flow volume (ml/s)
Baseline
Portal vein diameter (in mm) measured by grey scale ultrasound at liver hilum
Portal vein diameter (in mm) measured by grey scale ultrasound at liver hilum (longitudinal axis)
Baseline
Portal vein Doppler assessment of flow direction (hepatopetal or hepatofugal)
Ultrasound Doppler assessment of portal vein flow direction (hepatopetal or hepatofugal)
Baseline
Portal vein Doppler assessment of flow pulsatility (yes or no)
Ultrasound Doppler assessment of portal vein pulsatility (yes or no)
Baseline
Portal vein Doppler assessment of flow phasicity (monophasic, biphasic or triphasic)
Ultrasound Doppler assessment of portal vein flow phasicity (monophasic, biphasic or triphasic)
Baseline
Portal vein quantitative Doppler measurement of maximum flow rate (cm/s)
Ultrasound Doppler quantitative measurement of portal vein maximum flow rate (cm/s)
Baseline
Portal vein quantitative Doppler measurement of minimum flow rate (cm/s)
Ultrasound Doppler measurement of portal vein minimum flow rate (cm/s)
Baseline
Portal vein quantitative Doppler measurement of pulsatility index (only if pulsatility is present)
Ultrasound Doppler quantitative measurement of portal vein pulsatility index
Baseline
Portal vein quantitative Doppler measurement of flow volume (ml/s)
Ultrasound Doppler measurement of portal vein flow volume (ml/s)
Baseline
Eligibility Criteria
Patients attending Hong Kong Children's Hospital for clinically indicated USG examination will be invited to participate in this study.
You may qualify if:
- Patient \< / = 18 years of age.
- No history of hepatobiliary nor cardiac pathology as checked with record in ePR. Verbal confirmation will be done with patient or parent / legal guardian.
- Attending USG study other than that of the hepatobiliary system. (ie. Patients attending for thyroid USG, urinary system USG, musculoskeletal system USG etc.)
You may not qualify if:
- Patient \> 18 years of age
- Known history of hepatobiliary or cardiac pathology.
- Unstable patients.
- Intolerance of USG examination
- Uncooperative patients.
- Patient requiring sedation for USG study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hong Kong Children's Hospital
Hong Kong, Hong Kong
Related Publications (8)
Patriquin HB, Perreault G, Grignon A, Boisvert J, Filiatrault D, Garel L, Blanchard H. Normal portal venous diameter in children. Pediatr Radiol. 1990;20(6):451-3. doi: 10.1007/BF02075206.
PMID: 2392362BACKGROUNDSoyupak S, Gunesli A, Seydaoglu G, Binokay F, Celiktas M, Inal M. Portal venous diameter in children: normal limits according to age, weight and height. Eur J Radiol. 2010 Aug;75(2):245-7. doi: 10.1016/j.ejrad.2009.03.052. Epub 2009 May 5.
PMID: 19409745BACKGROUNDWeinreb J, Kumari S, Phillips G, Pochaczevsky R. Portal vein measurements by real-time sonography. AJR Am J Roentgenol. 1982 Sep;139(3):497-9. doi: 10.2214/ajr.139.3.497. No abstract available.
PMID: 6981312BACKGROUNDJequier S, Jequier JC, Hanquinet S, Gong J, Le Coultre C, Belli DC. Doppler waveform of hepatic veins in healthy children. AJR Am J Roentgenol. 2000 Jul;175(1):85-90. doi: 10.2214/ajr.175.1.1750085.
PMID: 10882252BACKGROUNDHerbetko J, Grigg AP, Buckley AR, Phillips GL. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography. AJR Am J Roentgenol. 1992 May;158(5):1001-5. doi: 10.2214/ajr.158.5.1566656.
PMID: 1566656BACKGROUNDMcCarville MB, Hoffer FA, Howard SC, Goloubeva O, Kauffman WM. Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings. Pediatr Radiol. 2001 Feb;31(2):102-5. doi: 10.1007/s002470000373.
PMID: 11214676BACKGROUNDHommeyer SC, Teefey SA, Jacobson AF, Higano CS, Bianco JA, Colacurcio CJ, McDonald GB. Venocclusive disease of the liver: prospective study of US evaluation. Radiology. 1992 Sep;184(3):683-6. doi: 10.1148/radiology.184.3.1509050.
PMID: 1509050BACKGROUNDCorbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018 Feb;53(2):138-145. doi: 10.1038/bmt.2017.161. Epub 2017 Jul 31.
PMID: 28759025BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Pui Kwan Joyce Chan, MBChB
Hong Kong Children's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate consultant radiologist, Deputy Head of Ultrasound team of radiology, Principle investigator
Study Record Dates
First Submitted
October 29, 2020
First Posted
November 6, 2020
Study Start
November 1, 2020
Primary Completion
July 31, 2024
Study Completion
December 31, 2024
Last Updated
February 29, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share